Difference between revisions of "Mianserine-trazodone"

From Psychiatrienet
Jump to: navigation, search
 
(3 intermediate revisions by one other user not shown)
Line 3: Line 3:
 
| to = trazodone  
 
| to = trazodone  
 
| stop =  
 
| stop =  
* '''Before day 0:''' gradually reduce the dosage of mianserine to a maximum of 60 mg/day.
+
* '''Before day 1:''' gradually reduce the dosage of mianserine to a maximum of 60 mg/day.
 
* '''Day 1:''' reduce dosage of mianserine to 30 mg/day.
 
* '''Day 1:''' reduce dosage of mianserine to 30 mg/day.
 
* '''Day 8:''' stop administration of mianserine.
 
* '''Day 8:''' stop administration of mianserine.
 
| start =  
 
| start =  
* '''Day 9:'''Start administration of trazodone in a dosage of 100-150 mg/day
+
* '''Day 9:''' Start administration of trazodone in a dosage of 100-150 mg/day
* If necessary, increase dosage of trazodone to a maximum of 400 mg/day.}}
+
* '''Day 16:''' If necessary, increase dosage of trazodone to a maximum of 400 mg/day.}}

Latest revision as of 15:14, 17 November 2009

Mianserine
Type Antidepressant
Group other
links
PubChem 4184
PubMed Mianserine
Kompas (Dutch) Mianserine
Wikipedia Mianserine
Trazodone
Type Antidepressant
Group other
links
Medscape Trazodone
PubChem 5533
PubMed Trazodone
Kompas (Dutch) Trazodone
Wikipedia Trazodone

Switch medication from mianserine to trazodone.[1] [2]

Nietinrijdenbord.png Stop mianserine
  • Before day 1: gradually reduce the dosage of mianserine to a maximum of 60 mg/day.
  • Day 1: reduce dosage of mianserine to 30 mg/day.
  • Day 8: stop administration of mianserine.
Eenrichtingbord.png Start trazodone
  • Day 9: Start administration of trazodone in a dosage of 100-150 mg/day
  • Day 16: If necessary, increase dosage of trazodone to a maximum of 400 mg/day.


  1. Switches are based on literature references on this page and expert opinions of the authors. The authors have used pharmacokinetic and receptor affinity properties to determine the switch schedules
  2. Stahl, S. M. (2013). Stahl's essential psychopharmacology: Neuroscientific basis and practical applications (4th ed.). Cambridge University Press.
The editors of psychiatrienet.nl take the greatest care to provide up-to-date and accurate information on this site. Nevertheless, mistakes and omissions cannot be entirely excluded. No rights devolve from the information provided. The editors and other providers of information to this site accept no responsibility for the content of this site or for the information provided therein; neither do they accept responsibility for possible damages which may derive from the use of the information on this site or from the linked sites. The editorial board accepts no responsibility for the content of the (linked) sites, for access to them, or for the products and services on these sites, nor for the occurrence of errors, viruses, and/or disruptions in service.